Evaluation of the neuroprotective effect of ketoprofen on rats submitted to permanent focal brain ischemia

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 4 A, 2007, Pages 978-984

  Da Silva, Manoel Nunes ^a,b   Colli, Benedicto Oscar ^a,b   Coimbra, Norberto Cysne ^a,c   Netto, Joaquim Coutinho ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Division of Neurosurgery

^c Department of Pharmacology ^*

Author keywords

Focal brain ischemia; Glutamate; Histopathology; Ketoprofen; Neuroprotection; Open field; Rat

Indexed keywords

GLUTAMIC ACID; KETOPROFEN;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEFECATION; EXPLORATORY BEHAVIOR; HISTOPATHOLOGY; MIDDLE CEREBRAL ARTERY; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; PREOPERATIVE EVALUATION; RAT; STATISTICAL ANALYSIS; WEIGHT CHANGE; WISTAR RAT;

EID: 37649001483     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2007000600011     Document Type: Article

References (31)

1. Tamura A, Graham DI, Mcculloch J, Teasdale GM. Focal cerebral ischemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981;1:53-60.
2. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989;20:1627-1642.
3. Paxinos, G. The rat nervous system. 2.Ed. San Diego: Academic Press, 1995.
4. Silva MN. Contribuição ao estudo morfológico do círculo arterioso do cérebro (polígono de Willis) de ratos. Dissertação, Ribeirão Preto, 1998.
5. Ridenour TR, Warner DS, Todd MM, Baker MT. Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat. Brain Res 1991;565:116-122.
6. Wahl F, Allix M, Plotkine M, Boulu RG. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 1992;23:267-272.
7. Graham SH, Chen J. Limiting ischemic injury by inhibition of excitatory amino acid release. J Cereb Blood Flow Metab 1993;13:88-97.
8. Benveniste H, Drejer J, Schousboe A, Diemer N. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984;43:1369-1374.
9. Phillis JW, Smith-Barbour M, Perkins LM, O'regan MH. Indomethacin modulates ischemia-evoked release of glutamate and adenosine from the rat cerebral cortex. Brain Res 1994:571:353-356.
10. McCormak K. Non steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994;59:9-43.
11. Woolf CJ. Generation of acute pain: central mechanisms. Br Med Bull 1991; 47:523-533.
12. Asanuma M, Asanuma S, Gómez-Vargas M, Yamamoto M, Ogawa ND. Ketoprofen, a non-steroidal anti-inflammatory drug prevents the late onset of muscarinic receptors in gerbils hippocampus after transient forebrain ischaemia. Neurosci Lett 1997;255:193-204.
13. Dias LAA, Colli BO, Netto JC, Lachat JJ. Avaliação da isquemia cerebral focal induzida pela oclusão da artéria cerebral média e a ação neuroprotetora do cetoprofeno em ratos. Arq. Neuropsiquiatr 2000;58:1047-1054.
14. Morton DB. The animals (Scientific Procedures) act 1986 and research into anaesthesia. Br J Anaesth 1990;65:303-305.
15. Flecknell PA. Anaesthesia of animals for biomedical research. Br J Anaesth 1993;71:885-894.
16. 1-opioid receptor. Brain Res 2001;903:216-221.
17. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke 1986;17:472-476.
18. Shiraishi K, Simon RP. A model of proximal middle cerebral artery occlusion in rat. J Neurosci Meth 1989;30:169-174.
19. Silva MN. Avaliação do efeito neuroprotetor do ketoprofen em ratos submetidos à isquemia encefálica focal permanente. Tese. Ribeirão Preto, 2003.
20. Carlotti CG Jr, Colli BO, Kazuo JY. Avaliação da isquemia cerebral pela respiração mitocondrial: modelo experimental. Arq Neuropsiquiatr 2002;59:335-371.
21. Lindroth P, Mopper K. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn derivatization with o-phtalaldehyde (OPA). Anal Chem 1979;51:1667-1674.
22. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 3.Ed. Sydney, Academic Press, 1997.
23. Colli BO, Silva MN, Carlotti CG Jr. Isquemia cerebral experimental. In Silva OC Jr, Zucoloto S, Beer A Jr (Eds). Modelos experimentais de pesquisa em cirurgia. São Paulo: Editora Robe, 1998:643-662.
24. Jiang N, Chopp M, Stein D, Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 1996;735:101-107.
25. Lei B, Cottrell JE, Kass I.S. Neuroprotective effect of low-dose lidocaine in a rat model of transient focal cerebral ischemia. Anesthesiology 2001;95:445-451.
26. Robinson RG. Differential behavior and biochemical effects of right and left hemispheric infarction in the rat. Science 1979;205:707-710.
27. Coutinho-Netto J, Abdul-Ghani AS, Collins JF, Bradford HF. Is glutamate a trigger factor in epileptic hyperactivity? Epilepsia 1981;22:289-296.
28. Baker CJ, Fiore AJ, Frazzini VI, Choudhri TF, Zuby GP, Solomon RA. Intraischemic hypothermia decreases the release of glutamate in the cores of permanent focal cerebral infarcts. Neurosurgery 1995;36:994-1002.
29. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001;69:369-381.
30. Gagliardi, R.J. Neuroprotection, excitotoxicity and NMDA antagonists. Arq Neuropsiquiatr 2000;58:583-588.
31. Santos WA. Aspectos bioquímicos e morfológicos da isquemia e reperfusão retiniana: estudo sobre a toxicidade excitatória, seus antagonistas e outros mediadores da lesão neuronal isquêmica. Tese. Ribeirão Preto, 1999.